glp-1 cancer reduction Could drugs reduce progression? Swipe to learn more 👉🏽 Reference: Orland M. Can GLP-1 receptor agonists mitigate cancer progression? A propensity-matched analysis across seven solid tumors. To be presented at Glucagon-like peptide 1 receptor agonists

Postgrad Med 127(8):818-26

It is going to take a lot for someone to wrestle that away from them, at least in the near future. And as for amylin analogs, Papamargaritis, the Leicester researcher, says that, based on current data, Lillys molecule is leading in terms of the amount of weight loss it can offer, but that doesnt mean the market doesnt have a place for other amylin analogs as well as drugs that target other receptors, such as glucagon

Prescribing information: TANZEUM (albiglutide) for injection, for subcutaneous use

Should I take a GLP-1

Off-label or Unlicensed Use of medicines: Prescribers Responsibilities [Internet]

C.ArnoldR.GokeB